CBChampica K. Bodinayake

Champica K. Bodinayake

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Champica K. Bodinayake has a total of 208 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    National Point-Prevalence Study Of Antibacterial Prescription In Public Hospitals In Sri Lanka

    by Subodha Wickramasinghe, W.M.D. Gaya Bandara Wijayaratne, Champica Bodinayake, Senali A. Weerasinghe, H. Harshani Pmj Thabrew, G.S.K Dharmaratne, Prasangika Priyarangani, A.A.DEepika Priyanthi, Balachandran Devakanthan, Vaithehi Rajeevan Francis, et al.

    Background: Antimicrobial resistance is a global health crisis that is driven by inappropriate antibacterial use. We studied the prevalence, patterns, and indications of antibacterial prescription in public hospitals in Sri Lanka. Methods: Single-day, point-prevalence surveys were conducted among inpatients in medical, surgical, pediatric wards, and intensive-care units (ICU) in 18 public hospitals in six provinces in Sri Lanka in Aug-Nov 2024. One each from tertiary, secondary, and primary-level hospitals were included per province. Data were collected from medical records. Findings: Of 3866 patients, 2327 were from tertiary, 1396 from secondary, and 141 from primary hospitals. Prevalence of antibacterial prescription in tertiary, secondary and primary hospitals was 56·7%, 52·6%, and 49·6%, respectively. The highest antibacterial prescription was in ICUs (92·9%).Among tertiary and secondary hospitals, commonly prescribed antibacterials were amoxicillin-clavulanate (20·4% of total number of antibacterials), third-generation cephalosporins (19·5%), and metronidazole (10·8%). Carbapenem prescription was 7·2% and 4·3% in tertiary and secondary hospitals, respectively and most common in ICUs (18·8%). Prescription of ‘Access’ group antibacterials was 58·3% in tertiary, 65·5% in secondary, and 91·3% in primary while prescription of ‘Reserve’ group was <1% across all facilities. Common indications for antibacterials were cellulitis/abscess/soft tissue infections (28·9%), and lower respiratory tract infections/pneumonia (25·2%). Associated microbiologic cultures were ordered in 37·5% patients in tertiary, 18% in secondary, and 0% in primary hospitals. Interpretation: Improving diagnostic capacity and reducing use of carbapenems were identified as antimicrobial stewardship targets. Funding: Duke Global Health Institute

  • Open Access

    Physician knowledge, attitudes, and perceptions of antibiograms: a pre-implementation study in southern Sri Lanka

    by Lorenna C. Garcia-Bochas, Sherine Nanayakkara, Perla Medrano, Ajith Nagahawatte, C. Lakmal Fonseka, Armstrong Obale, Bhagya Piyasiri, Ruvini Kurukulasooriya, Madureka Premamali, Ganga Moorthy, et al.

    Objective: The purpose of this study is to explore physicians’ knowledge, attitudes, and perceptions toward antibiograms and identify perceived barriers and facilitators to their implementation in a low-resource setting in Sri Lanka. Design: A qualitative study utilizing semi-structured interviews and thematic analysis. Setting: A public tertiary care hospital in southern Sri Lanka. Participants: Thirty physicians working in pediatric and adult medical wards were purposively sampled and interviewed between June and August 2023. Results: Most physicians had limited prior knowledge or experience with antibiograms. However, after receiving a brief explanation, 29 out of 30 participants expressed strong support for implementing antibiograms, citing potential benefits such as improved antibiotic prescribing, reduced antimicrobial resistance (AMR), and enhanced patient outcomes. Approximately one-third of participants expressed concerns about feasibility due to time constraints, limited laboratory infrastructure, and personnel shortages. Participants recommended delivering antibiogram training through small-group sessions led by a multidisciplinary team. Thematic analysis identified three core themes: (1) limited baseline knowledge of antibiograms, (2) perceived clinical value and enthusiasm for implementation, and (3) barriers related to healthcare system constraints. Conclusions: Physicians in this LMIC setting demonstrated high interest in using antibiograms to guide empiric antibiotic therapy and address AMR. Despite logistical and infrastructural challenges, tailored training and stakeholder engagement may facilitate the successful development and use of antibiograms in similar resource-limited settings.


  • Open Access

    Use of the BIOFIRE® FILMARRAY® Pneumonia plus Panel to characterize the etiology of lower respiratory tract infections among hospitalized patients in Southern Province, Sri Lanka

    by Zachary A. Weishampel, Ajith Nagahawatte, Gaya Wijayaratne, Subodha S. Wickramasinghe, Bradly Nicholson, Jack Anderson, Sky Vanderburg, Chathuranga Lakmal Fonseka, Madureka Premamali, Robert J. Rolfe, et al.

    Lower respiratory tract infections (LRTIs) account for a heavy burden of illness in low- and middle-income country settings, but the etiology of these infections is often unknown. In this study, we applied the BIOFIRE® FILMARRAY® Pneumonia plus Panel, a multiplex polymerase chain reaction assay with bacterial, viral, and antibacterial resistance gene targets, on sputum samples to evaluate the etiology of community-acquired LRTI among hospitalized patients in southern Sri Lanka. We enrolled children and adults hospitalized with LRTIs at a public tertiary care hospital in southern Sri Lanka from 2019 to 2021. Demographic and clinical data were collected, and a sputum sample for each patient was tested using the Pneumonia plus Panel. Assay results were compared with sputum culture results. Fisher’s exact test was applied to identify association between the presence of viruses, bacteria, or antimicrobial resistant genes and the findings of the chest radiographs during hospitalization as well as associations between the genomic concentration identified through the panel and the bacteria known to cause typical pneumonia infection included in the panel. In 267 patients tested, the most detected bacteria by the Pneumonia plus Panel were the Klebsiella pneumoniae group (41.9%), Staphylococcus aureus (34.5%), and the Acinetobacter calcoaceticus-baumannii complex (32.6%). The most detected viruses were the human rhinovirus/enterovirus (19.5%) and influenza A (10.9%). In total, 211 patients (79.0%) had at least one gram-negative bacterium and 139 patients (52.1%) had at least one gram-positive bacteria. As for Antimicrobial Resistance, 96 patients (40.0%) had at least one carbapenem resistant gene, 56 patients (21.0%) had an extended spectrum beta-lactamase related gene, and 42 patients (15.7%) had a methicillin resistant gene. Only 15 patients (5.6%) were identified to have Pneumonia plus Panel results matching with sputum culture results. Our findings suggest that patients with LRTI in Southern Province, Sri Lanka have a high prevalence of gram-negative bacteria and antibacterial resistance in their sputum samples. However, it remains difficult to differentiate isolates that are colonizers not leading to disease versus the true cause of infection via the use of the BIOFIRE® FILMARRAY® Pneumonia plus Panel on sputum samples.


  • Open Access

    Academic global health collaboration: the Ruhuna-Duke partnership

    by Champica K Bodinayake, Ajith De S Nagahawatte, Vijitha de Silva, P L Ariyananda, Bilesha Perera, Ruvini Kurukulasooriya, M H Madureka Premamali, Christopher W Woods, L Gayani Tillekeratne, Truls Østbye

    The role of institutional partnerships is increasingly recognized as a means of advancing our collective efficacy in improving public health. Shared challenges related to infectious and chronic diseases, as well as social determinants of health including environmental stressors, have led to a growth in academic global health collaborations. Triggered by the 2004 tsunami, the University of Ruhuna, Sri Lanka, and Duke University, USA, established an educational and research collaboration that has been sustained and broadened over two decades. The initiation and development of the collaboration, as well as its educational and research components, are described in this manuscript. We discuss lessons learned that may be of interest to other emerging partnerships: the keys to the collaboration's success, challenges and barriers faced, as well as plans to sustain and further grow an equitable, academically rigorous, and impactful global health partnership.

  • Open Access

    Electronic Clinical Decision Support Tools to Manage Patients with Lower Respiratory Tract Infection: Clinicians’ Perspectives in Sri Lanka

    by Warsha De Zoysa, Dhammika Palangasinghe, Champica Bodinayake, Ajith Nagahawatte, Jayani Gamage, Maria D. Iglesias-Ussel, Stefany Olague, Christina Galdieri, Ruvini Kurukulasooriya, Senali Weerasinghe, et al.

    : In low-resource settings, providers often manage lower respiratory tract infections (LRTIs) without diagnostic tests, which may cause antibacterial overuse. Electronic clinical decision support tools (eCDSTs) can support evidence-based decision-making and judicious use of antibacterials. This study aimed to explore the potential of an eCDST to help providers in Sri Lanka effectively manage LRTI. Semi-structured interviews were conducted with 15 clinicians, including 10 males and five females, with an average of 11.6 years (range: 4–25 years) of clinical practice. The interview guide covered clinicians’ interest in an eCDST to manage LRTI and their feedback regarding the desired features of such a tool. Interviews were audio-recorded, transcribed, and coded for themes related to: interest in an eCDST for LRTI, desired tool capabilities, development concerns, and tool design characteristics. All expressed interest in incorporating eCDSTs into their practice. However, the majority emphasized that clinical judgment must supersede recommendations from an eCDST. Four themes emerged regarding desired tool capabilities: information about the pathogen, treatment recommendations, severity of the LRTI, and monitoring of patient progress. Six themes emerged regarding tool development considerations: validated algorithms, regional specificity, seasonality, inclusion of patient’s risk factors, scalability, and the importance of updated and locally relevant recommendations. Participants stressed that the tool design should be simple, timesaving, and internet-independent. Electronic clinical decision support tools are capable of improving patient care and reduce antibiotic overuse, which may impact downstream antibacterial resistance. Future research should develop an eCDST for LRTI with local input and evaluate its impact on appropriate antibacterial use and patient outcomes.

  • Open Access

    Prevalence of anxiety and depression among patients hospitalised with acute febrile illness

    by C. K. Bodinayake, A. De S. Nagahawatte, W. S. Ranaweera Arachchige, S. C. Sahabandu, A. H. Pushpakumara, P. K. Wijayaratna, B. N. Jayasekera, L. G. Tillekeratne

    Introduction: Acute febrile illnesses (AFI) such as dengue, leptospirosis, and influenza result in large numbers of hospitalisation in the tropics. These illnesses may negatively impact patients’ mental health. The prevalence of anxiety and depression and risk factors associated with these conditions were evaluated in patients hospitalised with AFI. Methods: From July- October 2017, a cross-sectional study was conducted on consecutive patients ≥12 years of age admitted with AFI to a tertiary care hospital in Sri Lanka. The validated Sinhala translation of Hospital Anxiety and Depression Scale (HADS) was administered to identify the presence and severity of anxiety and depression. The prevalence of anxiety and depression was identified and the association with sociodemographic and clinical characteristics was determined using Chi square and t-tests and multivariable logistic regression. Results: Of 193 enrolled, 44.6% were male. AFI included dengue (62.7%), viral fever (10.4%), urinary tract infection (6.2%), leptospirosis (4.7%), pneumonia (3.1%) and typhus (0.5%). Overall, 41.4% patients had anxiety and 42.5% had depression. On multivariable analysis, anxiety was associated with awareness of diagnosis (OR=4.3, CI 1.3-13.76, p=.03), lower satisfaction score (OR=0.73, CI 0.58-0.92, p=0.008) and lower income (OR=1.92, CI 1.03-3.57, p=0.03). Depression was associated with anorexia (OR=2.8, CI 1.33-5.87, p=0.006) and diarrhoea (OR=2.29, CI 1.17-4.47, p=0.01).Conclusions: Patients hospitalised with AFI had a high prevalence of anxiety and depression. Gastrointestinal symptoms, lower socioeconomic status, and awareness of diagnosis of illness were all associated with anxiety. Our findings may be helpful in developing interventions to counteract anxiety and depression among patients hospitalised with AFI.

  • Open Access

    Electronic Clinical Decision Support Tools: Strategies to Improve the Management of Lower Respiratory Tract Infections in Low-Resource Settings

    by L. Gayani Tillekeratne, Warsha De Soyza, Maria D. Iglesias-Ussel, Stefany Olague, Dhammika Palangasinghe, Ajith Nagahawatte, Thilini Wickramatunga, Jayani Gamage, Ruvini Kurukulasooriya, Madureka Premamali, et al.

    : Lower respiratory tract infection (LRTI) is a common reason for hospitalization and antibacterial use globally. There is considerable overlap in the clinical presentation of bacterial and viral LRTIs. Low- or middle-income countries (LMICs) face the dual challenge of appropriately targeting antibacterials for bacterial LRTI while reducing inappropriate antibacterials for viral LRTI. We propose a framework by which an electronic clinical decision support tool (eCDST) for diagnosing LRTI and reducing unnecessary antibacterial use may be developed, validated, and prospectively evaluated in an LMIC. The developed tool would be data driven, low-cost, feasible in the local setting, adaptable based on resource availability, and updated in real time, with prospective assessment to identify its clinical impact. We draw upon our team’s recent experience developing an eCDST for LRTI management in Sri Lanka. Publicly sharing such processes and data is valuable, such that we can collectively improve clinical care in LMICs and other settings.


  • Open Access

    Prevalence and predictors of antibiotic prescription among patients hospitalized with viral lower respiratory tract infections in Southern Province, Sri Lanka

    by Perla G. Medrano, Nayani Weerasinghe, Ajith Nagahawatte, Sky Vanderburg, Lawrence P. Park, Gaya B. Wijayaratne, Vasantha Devasiri, Buddhika Dilshan, Tianchen Sheng, Ruvini Kurukulasooriya, et al.

    Background: Antimicrobial overprescription is common for lower respiratory tract infections (LRTI), as viral and bacterial infections generally present with similar clinical features. Overprescription is associated with downstream antimicrobial resistance. This study aims to identify the prevalence and predictors of antibiotic prescription among patients hospitalized with viral LRTI. Methods: A prospective cohort study was conducted among patients aged ≥1 year hospitalized with viral LRTI in a tertiary care hospital in Southern Province, Sri Lanka from 2018–2021. Demographic, clinical, and laboratory data were recorded. Nasopharyngeal and blood samples were collected for multiplex polymerase chain reaction testing for 21 respiratory pathogens and procalcitonin (PCT) detection, respectively. Demographic and clinical features associated with antibiotic prescription were identified using Chi Square and t-tests; significant variables (p<0.05) were further included in multivariable logistic regression models. The potential impact of biomarker testing on antibiotic prescription was simulated using standard c-reactive protein (CRP) and PCT cut-offs. Results: Of 1217 patients enrolled, 438 (36.0%) had ≥1 respiratory virus detected, with 48.4% of these patients being male and 30.8% children. Influenza A (39.3%) and human rhinovirus/ enterovirus (28.3%) were most commonly detected. A total of 114 (84.4%) children and 266 (87.8%) adults with respiratory viruses were treated with antibiotics. Among children, neutrophil percentage (median 63.6% vs 47.6%, p = 0.04) was positively associated with antibiotic prescription. Among adults, headache (60.6% vs 35.1%, p = 0.003), crepitations/crackles (55.3% vs 21.6%, p<0.001), rhonchi/wheezing (42.9% vs 18.9%, p = 0.005), and chest x-ray opacities (27.4% vs 8.1%, p = 0.01) were associated with antibiotic prescription. Access to CRP and procalcitonin test results could have potentially decreased inappropriate antibiotic prescription in this study by 89.5% and 83.3%, respectively. Conclusions: High proportions of viral detection and antibiotic prescription were observed among a large inpatient cohort with LRTI. Increased access to point-of-care biomarker testing may improve antimicrobial prescription.


  • Open Access

    High prevalence of anxiety and depression among patients hospitalized with acute febrile illness in Sri Lanka

    by Champica K. Bodinayake, Ajith De. Silva Nagahawatta, Wasana Sevwandi Ranaweera Arachchige, Senuri C Sahabandu, Aruna H. Pushpakumara, Piyumi Wijayarathna, Bhagya Jayasekhara, Gayani Thilakarathna, Piumi K. Wijayaratna, L. Gayani Tillekeratne

    Introduction Acute febrile illnesses (AFI) such as dengue, leptospirosis, and influenza result in large numbers of hospitalization in the tropics. These illnesses may negatively impact patients’ mental health. We evaluated the prevalence of anxiety and depression and risk factors associated with these conditions in patients hospitalized with AFI. Methodology From July-October 2017, we conducted a cross-sectional study of consecutive patients ≥12 years admitted with AFI to a tertiary care hospital in Sri Lanka. We administered the Hospital Anxiety and Depression Scale (HADS) validated in the local language of Sinhala to identify the presence and severity of anxiety and depression. We identified the prevalence of anxiety and depression and determined the association with sociodemographic and clinical characteristics using Chi square and t-tests and multivariabele logistic regression. Results Of 193 enrolled, 44.6% were male. AFI included dengue (62.7%), viral fever (10.4%), urinary tract infection (6.2%), leptospirosis (4.7%), pneumonia (3.1%) and typhus (0.5%). Overall, 41.4% patients had anxiety and 42.5% had depression. On multivariable analysis, anxiety was associated with awareness of diagnosis (OR=4.3, CI 1.3-13.76, p=.03), lower satisfaction score (OR=0.73, CI 0.58-0.92, p=.008) and lower income (OR=1.92, CI 1.03-3.57, p=.03). Depression was associated with anorexia (OR=2.8, CI 1.33-5.87, p=.006) and diarrhea (OR=2.29, CI 1.17-4.47, p=.01). Conclusions Patients hospitalized with AFI had a high prevalence of anxiety and depression. Gastrointestinal symptoms, lower socioeconomic status, and awareness of illness diagnosis were all associated with anxiety. Our findings may be helpful in developing interventions to counteract anxiety and depression among patients hospitalized with AFI.


  • Open Access

    Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance

    by Emily R. Ko, Megan E. Reller, L. Gayani Tillekeratne, Champica K. Bodinayake, Cameron Miller, Thomas W. Burke, Ricardo Henao, Micah T. McClain, Sunil Suchindran, Bradly Nicholson, et al.

    Diagnostic limitations challenge management of clinically indistinguishable acute infectious illness globally. Gene expression classification models show great promise distinguishing causes of fever. We generated transcriptional data for a 294-participant (USA, Sri Lanka) discovery cohort with adjudicated viral or bacterial infections of diverse etiology or non-infectious disease mimics. We then derived and cross-validated gene expression classifiers including: 1) a single model to distinguish bacterial vs. viral (Global Fever-Bacterial/Viral [GF-B/V]) and 2) a two-model system to discriminate bacterial and viral in the context of noninfection (Global Fever-Bacterial/Viral/Non-infectious [GF-B/V/N]). We then translated to a multiplex RT-PCR assay and independent validation involved 101 participants (USA, Sri Lanka, Australia, Cambodia, Tanzania). The GF-B/V model discriminated bacterial from viral infection in the discovery cohort an area under the receiver operator curve (AUROC) of 0.93. Validation in an independent cohort demonstrated the GF-B/V model had an AUROC of 0.84 (95% CI 0.76–0.90) with overall accuracy of 81.6% (95% CI 72.7–88.5). Performance did not vary with age, demographics, or site. Host transcriptional response diagnostics distinguish bacterial and viral illness across global sites with diverse endemic pathogens.